The GRO platform expands the amino acid alphabet to overcome the limitations of protein therapeutics currently impeding the treatment of disease
Our platform comprises Genomically Recoded Organisms (GROs) — the first production organisms with modified genomes and engineered protein translational machinery for high-efficiency production of non-standard amino acid (NSAA) proteins at commercial scale. NSAAs enhance proteins with capabilities inaccessible to the 20 standard amino acids such as unprecedented duration of action and precise control of the immune system.
Click on the hotspots below to see how GROs uniquely enable scalable production of NSAA proteins.
NSAA protein production in a standard organism

NSAA protein production in a Genomically Recoded Organism (GRO)
